Who Is Immune to Zika?

Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.

Written byAmanda B. Keener
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Zika virus distribution as of January 15, 2016WIKIMEDIA, CDCViral immunologist Eva Harris has been tracking dengue virus infections in Nicaragua for more than two decades. During the last nine months, her lab has taken on more than 40 new projects, all related to Zika virus. Many of these latest studies take advantage of blood samples donated as parts of various dengue surveillance projects, including one cohort of 3,500 Nicaraguan children who have given blood annually for several years. This cohort and others like it are providing researchers with an inside look at of how Zika spreads in a naive population, and how it interacts with dengue. “We can now analyze Zika infections in children who we know have had a previous dengue infection or not,” said Harris, a professor of infectious diseases and vaccinology at the University of California, Berkeley School of Public Health.

Examining existing cohorts, researchers hope to answer basic questions about the epidemiology of this emerging virus. For one, have certain populations acquired herd immunity as a result of previous exposure to Zika?

“Is it true that there hasn’t been Zika around the world?” asked Isabel Rodriguez-Barraquer, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health in Baltimore. “Or has it been there, but we haven’t found it?”

Rodriguez-Barraquer and colleagues are looking for antibodies against Zika in 10,000 blood samples from ongoing dengue studies in Colombia, Thailand, India, and parts of Africa. The US National Institutes of Health (NIH) and the Thai Armed Forces Research Institute of Medical Sciences, meanwhile, will add retrospective and prospective Zika surveillance to existing dengue cohort studies in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies